patient_bedAt the American Society of Clinical Oncology’s annual conference in Chicago, Siemens presented advanced imaging solutions for selective internal radiation therapy (SIRT), an innovative therapy procedure for inoperable liver cancers.

Over the past years, interventional procedures such as SIRT, also known as radioembolization, started to play a more meaningful role in the treatment of tumors. However, the application of such effective local therapies was limited to experienced centers in order to reduce the risks of treatment-related complications that can occur if targeted therapies are inadvertently applied outside the target organ. More recently, with the introduction of advanced imaging technology such as Siemens Artis angiography systems, the safety of application could be further improved due to advanced image guidance.

“With the advanced technology of our angiographic systems (Artis systems) and Syngo reading software, Siemens enables health care professionals to perform more complex interventional procedures—even for patients in poor physical condition. That will change the way liver cancer can be treated,” said Wieland Voigt, associate professor and leader of Siemens Clinical Competence Center Oncology. “Siemens looks forward to further advancing interventional oncology with our innovative imaging systems and technologies.”

The company also debuted new technologies designed to expand the capabilities and improve the productivity of molecular imaging at the recent meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Baltimore.

Symbia Evo, Siemens’ new single-photon emission computed tomography (SPECT) system, boosts user productivity, providing facilities with more time to plan treatment schedules, personalize studies, serve additional patients, and improve workflow efficiency. At the show, the company unveiled the Biograph RT Pro edition, which leverages the premium positron emission tomography (PET) and CT technologies of the Biograph mCT family of large-bore scanners for radiation therapy (RT) treatment.

Additionally, Siemens introduced advanced RT functionality on its syngo.via for molecular imaging software solution that, with the Biograph RT Pro edition, provides flexible post-processing options that can be tailored to the clinical and workflow needs of both nuclear medicine and radiation oncology departments.

For more information, visit Siemens Healthcare.

Get AXIS e-newsletters free. Subscribe here.